The beneficiary, VitaSynth Sp. z o.o., is implementing the project titled "Implementation of R&D work on innovative technology for chemical synthesis of vitamin K2(MK-7)” As part of the Regional Operational Program of the Mazovian Voivodeship 2014-2020 (ROP WM 2014-2020). AXIS III Development of innovation potential and entrepreneurship. Measure: 3.3 Innovation in SMEs. Intake number:RPMA.03.03.00-IP.01-14-122/22
The aim of the project is to launch a new product with increased purity on the market by using the results of R&D work carried out in-house. Implementation of the project is the result of own R&D work on the development of chemical synthesis of vitamin K2 (MK7). The project uses the effects of another project for which the Applicant received a grant under the WM ROP 2014-2020 Measure 1.2 Research and development activities of enterprises" (conducting R&D work). Implementation of the project will have a positive impact on the Company's employment policy and the environment. As a result of the project, the Company will implement an innovative solution on the market, thereby increasing its competitiveness and acquiring new customers.
Total value of the project: 708 610,00 PLN Amount of eligible expenditure: 707 000,00 PLN Grant amount: 565 600,00 PLN
Recommending a project to receive funding (revised list of projects selected for funding - List of positively evaluated projects approved by the amending resolution of 16 October 2023 on the approval of the list of evaluated projects, submitted under the competition RPMA.03.03.00-IP.01-14-122/22, Priority Axis III "Development of innovation potential and entrepreneurship" for Measure 3.3 "Innovation in SMEs", Type of projects: "Marketing of new or improved products or services" of the Regional Operational Program of the Mazowieckie Voivodeship for 2014-2020 - [Publication 17/10/2023]. Publikacja pdf nr 1
PROCEDURE 1 Commencement of proceedings for the purchase of a fixed asset: CO2 extractor - 10.11.2023. Link
Signing of funding agreement: 15.11.2023 r.
RESOLUTION OF PROGRESS 2 and selection of the entity to execute the contract: SFE PROCESS S.A.S - 22.11.2023 r. Publikacja pdf nr 2
Completion of PROCEDURE 2: signing of supply contract – 27.11.2023 r.
Completion of deliveries in the project and signing of the acceptance protocol – 28.12.2023 r. Publikacja pdf nr 3
Manufacturer: VitaSynth Sp. z o.o. ul. Szałwiowa 2, 03-167 Warsaw, Poland Dilutions site: EuroPharma Alliance Sp. z o.o. Aleja Led 1, 55-020 Rzeplin, Poland